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Abstract 
Background: Attention-deficit/hyperactivity disorder (ADHD) is a 
common mental disorder in adults. The objective of this study was to 
develop a valid Persian version of the 18-question ASRS-V1.1 
according to WHO translation protocol and report its psychometric 
properties. 
Methods: In the first step, we translated the original 18-question 
ASRS-V1.1 version into Persian under the supervision of the WMH-
CIDI advisory committee. The process of adaptation was consisting of 
forward-translation, expert panel evaluation, back translation, cross-
cultural adaptation, pre-testing, and final adjustment. In the second 
step, we conducted a cross-sectional study with 734 students were 
studied in Shahroud in 2013. A sub-sample of subjects consists of 99 
students were clinically interviewed according to DSM-IV-TR criteria 
by a well-trained physician. 
Results: The ASRS-V1.1-P had satisfactory internal consistency 
(Cronbach’s alpha = 0.85). Sensitivity and specificity for the first six 
questions of ASRS-V1.1-P were 50.0% (95% CI: 30.3-69.6) and 80.5% 
(95%CI: 70.7-88.3), respectively. Finally, 43 subjects (5.5%) were 
confirmed for adult ADHD. There was not sex predominance in the 
prevalence of ADHD. 
Conclusions: Totally, it may be concluded that adult ADHD is a 
common problem among students and prevention of this disorder is 
crucial to reduce the probable subsequent social, educational, and job 
problems in future. The 18-question ASRS-V1.1-P is a psychometrically 
reliable and valid measure for screening ADHD in adults. 
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Introduction 
Adult attention-deficit/hyperactivity disorder (ADHD) is a 
psychiatric condition among children and the results of some 
studies showed that it often can persist into adulthood for some 
patients.1,2 ADHD is characterized by improper levels of 
inattention and/or hyperactivity-impulsivity that lead to 
clinically significant changes in functional and psychosocial 
behavior.3 The symptoms of ADHD in adults are not clear like 
children, so in many adult cases the disorder may not be 
distinguishable4 and only 10% of the population who are 
suspected to have ADHD were diagnosed and received 
treatment.5 In addition, comorbidity of ADHD with other 
psychiatric conditions makes it difficult for the diagnosis of 
adult ADHD. The prevalence of ADHD was reported at 1-
7%.6-8 The incidence and prevalence estimation of this disorder 
may be biased by various factors, such as background and 
methodological differences as well as differences in diagnostic 
criteria and medical classification systems.7 Age, sex8 and 
subtypes of ADHD9 can effect on prevalence distribution of 
this condition.  
In recent decades, attention has been paid to ADHD and its 
screening in adults, because ADHD can impact on the social 
relationships, career, and even the individual quality of life.10,11 
Many adults may have symptoms of the disease but do not 
receive proper treatment because of the difficulty of diagnosing 
this disease in adults and adult ADHD remains 
underdiagnosed. Therefore, it is important to use screening 
criteria to estimate the prevalence and identification of patients. 
The available scales for screening are Conners’ adult ADHD 
rating scales-self-report12 and Adult ADHD self-report scale 
(ASRS-v1.1) symptom checklist.13 Conners’ adult ADHD 
rating scales-self-report includes 30 questions with 0 to 3 
points. It can be used for assessing the Inattention/memory 
problem, Restlessness/hyperactivity, Emotional 
instability/impulsiveness and D: Problems concerning general 
self-image.14 Arabgol et al. has been normalized it on 20 
students of Shahid Beheshti university of medical sciences, 
Iran. The reliability of this instrument has been reported 
acceptable with a Chronbach's alpha coefficient equal to 0.81.15 
The ASRS-v1.1 can identify adults requiring clinical 
evaluation for ADHD.13 This scale consists of 18 questions and 
developed for clinical and population-based studies. The 
questions in the ASRS v1.1 are consistent with DSM-IV-TR 
criteria and address the manifestations of ADHD symptoms in 
adults.13 It is a validated tool for assessing current ADHD 
symptoms in individuals aged 18 years or older, and it has not 
been translated into Persian. Therefore, the objective of this 
study was to prepare a valid Persian version of the 18-question 
ASRS-V1.1 according to WHO translation protocol and finally 
evaluate the validity and reliability of it on a group of college 
students. 
Materials and Methods  
In this study, ASRS-v1.1 was translated to Persian and 
psychometric properties in the screening of ADHD were 
evaluated in 734 Iranian students over 18 years old in 2013. 
The study was approved by the ethics committee of the 
Shahroud university of medical sciences (code number; 
920/36). All subjects provided a verbal informed consent prior 
to study participation and for clinical interviewing a written 
informed consent form was signed.  
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The participants were fulfilled two questionnaires including 
ASRS-V1.1-P and clinical interview checklist adapted on 
DSM-IV-TR criteria. The ASRS-V1.1 is one of several scales 
that were constructed in cooperation with the WHO-world 
mental health (WMH) survey initiative. The 18-question 
ASRS-V1.1 is a symptom checklist with two separate part (part 
A and B) that consisted of 18 ADHD symptoms asked how 
often the symptom occurred over the past 6 month’s period. 
part A consists of 6 items and these six questions are the basis 
for the ASRS screener. Part B of the scale contains the 
remaining twelve items. Each item has a 5-point scale in which 
0 = never, 1 = seldom, 2 = sometimes, 3 = often, 4 = very 
often. Its reliability and validity were demonstrated in the 
English version. The total score of this instrument ranged from 
0 to 72.13    
Translation of the instrument followed the standard WHO-
CIDI protocol after obtaining permission from the copyright 
holder and finally accepted as official by the WHO-world 
mental health-CIDI advisory committee. In short, 6 steps were 
followed for the translations to be approved: 
1. Original forward translation: in this section, the 
instrument along with instructions was translated to Persian by 
a Ph.D. of English language teaching and psychologist 
separately. In this process, the following tips were considered: 
translators should always aim at the conceptual equivalent of a 
word or phrase; it should strive to be simple; clear and concise; 
the target language should aim for the most common audience; 
translators should avoid the use of any jargon.  
2. Expert panel: A 7-person group consisting of two 
translators, a psychiatric, a general practitioner as well as two 
epidemiologists as survey methodologist were reviewed the 
primary translated versions. The result of a panel expert’s 
analysis produced a complete translated version of the 
instrument. The goal of expert panel analysis was to identify 
and detoxify the inadequate expressions of the translation, as 
well as any disagreement between the forward translations. 
3. Back-translation: The instrument was translated back to 
English by an independent translator (Ph.D. in English 
language teaching).  
4. International harmonization: At this important step, the 
final Persian version of ASRS and back-translated version 
distributed to the external expert panels in separate countries. 
This step was done by WHO-world mental health-CIDI 
advisory committee.   
5. Pre-testing and cognitive interviewing: In this step, we 
distributed the primary prepared ASRS-Persian to 10 persons 
(over 18 years old). We ask the subjects to describe what they 
understood the question to be asking, the ability to revival the 
item in their own words, what imagined when they heard a 
question, and to discuss how they choose their response. These 
questions repeated for each item. This information 
accomplished by in-depth personal interviews by a well-trained 
physician. Some minor modification was done during the pre-
testing of the questionnaire. 
6. Final version: The final version of the instrument was 
completed after all the iterations described above and finally 
approved by WHO-world mental health-CIDI advisory 
committee  
To evaluate the validity and reliability of this scale we 
conducted a cross-sectional study on a group of college 
students. In this study, 734 Iranian students were participated 
ranged in age from 18 to 50 years (mean age = 23.5 years, SD 
= 2.9) and 403 of them (54%) were females. Students were 
randomly selected using a multi-stage sampling method. The 
clusters were 27 educational majors. Students with 
psychosomatic comorbidities such as anxiety, depression and 
so on were excluded by completing a medical history taking.  
To investigate the psychometric properties of the ASRS we 
compared the ASRS screening results with a clinical interview 
with a group of screened subjects. Internal consistency was 
assessed using Cronbach’s alpha coefficient. Criteria validity 
was evaluated by calculating sensitivity, specificity of 
screening results comparing with clinical interview. 
Results 




Reliability: The internal consistency of the ASRS-v1.1-P 
using Cronbach’s α was 0.85 for the entire scale.   
Prevalence of ADHD: Using 6 items of part A, we screened 
104 students (14%) with symptoms highly consistent with 
ADHD. These are who responded with 4 or more checkmarks 
in the darkly shaded area of part A. The results of the study 
showed that there are no gender differences in the ASRS-v1.1-
P accounted prevalence (female = 13.0% and male = 16.9%; χ2 
= 2.1, Pvalue = 0.15).   
For further investigation, for all 104 screened students the 
other 12 items of ASRS-v1.1-P (part B) were assessed by the 
physician. Finally, 43 subjects (5.5%) were confirmed for adult 
ADHD. There was not sex predominance in the prevalence of 
ADHD.  
Criteria validity of ASRS-V1.1-P:  
The criteria validity was assessed by calculating the 
sensitivity and specificity from the results of the clinical 
psychiatric interview. A clinical interview using a semi-
structured interview according to the symptoms from the 
ADHD criteria in the DSM-IV-TR was done for 99 students. 
These students were selected randomly from all students who 
responded with 2 or more checkmarks in the dark area of part 
A related to the ASRS-v1.1-P scale. Finally, 22 students 
(22/99) were confirmed as ADHD using clinical interviews as 
the gold standard (hyperactive = 7, attention deficit = 9 and 
mix = 6). Sensitivity and specificity for the first six questions 
of ASRS-V1.1-P were 50.0% (95%CI: 30.3-69.6) and 80.5% 
(95%CI: 70.7-88.3), respectively (table 1). 
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Table 1. Comparison between results of clinical interview and ASRS-V1.1-
P screening scale in 99 students 
Test Clinical interview ADHD  Not ADHD 
ASRS screening scale   






Total  22 77 
Discussion 
The goal of this study was to prepare a valid Persian 
version of the ASRS-V1.1 scale and in the second step to 
assess the validity and reliability of the18-question ASRS-
V1.1-P for screening adult ADHD. The internal consistency 
using Cronbach’s coefficient was 0.85 which shows good 
internal consistency for this questionnaire. The internal 
consistency of the Japanese, Korean and Thai version of ASRS 
was over 0.70.16-18  
The sensitivity and specificity of ASRS-V1.1-P in our 
study were 0.50 and 0.80, respectively. This is in line with the 
results of the Japanese validation study (sensitivity = 0.67 and 
specificity = 0.84).18 
The estimated prevalence of ADHD in our report was 5.5% 
which is more prevalent than other studies.19 There were no sex 
differences in the prevalence of ADHD according to the ASRS 
screening scale. This result is contrary to the results of a meta-
analysis19 which found male predominant but is in line with 
findings of studies conducted in Korea and Australia.17,20 This 
difference can be interpreted by the fact that we estimated 
ADHD prevalence based on self-reported symptoms. In adults, 
unlike children, the sex ratio tends to be more identical.17 
Conducting this study on the student population is the main 
limitation of our study. Another limitation of this study is 
needed for adaptation of this scale to DSM-5 criteria. The new 
changes for the scale are available online at 
https://www.hcp.med.harvard.edu/ncs/ftpdir/adhd/ASRS-
5_Guidelines.pdf.  
Comparing the results of screening with the clinical 
investigation in the sub-sample of students as well as good 
observation in the adaptation process such as forward and 
backward translation are in the strength lists of this study.   
Totally, according to the obtained results in this study, it 
may be concluded that adult ADHD is a common problem 
among students and prevention of this disorder is crucial to 
reduce the probable subsequent social, educational, and job 
problems in future. The 18-question ASRS-V1.1-P is a 
psychometrically reliable and valid measure for screening 
ADHD in adults. Using 6-item part A is suitable for screening 
and diagnosis of ADHD needs further investigation like a 
review of entire symptoms (part B) and taking a good social, 
family and medical history. For assessing the effectiveness of 
this instrument in screening of ADHD further investigation is 
necessary. 
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